Cenobamate Expanded Access Program (EAP)

Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures

NCT01397968 ·Status: COMPLETED ·Phase: PHASE2

Randomized, Double-blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in POS

NCT04557085 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures

NCT03678753 ·Status: COMPLETED ·Phase: PHASE3

An Extended Access Program (EAP) for Perampanel

NCT02307578 ·Status: NO_LONGER_AVAILABLE

An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.

NCT00991757 ·Status: COMPLETED ·Phase: PHASE3

Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

NCT06590896 ·Status: RECRUITING ·Phase: PHASE2

Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy

NCT00228969 ·Status: COMPLETED ·Phase: PHASE2

A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures

NCT01866111 ·Status: COMPLETED ·Phase: PHASE2

Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current Antiepileptic

NCT01091662 ·Status: COMPLETED ·Phase: PHASE3

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

NCT00210652 ·Status: COMPLETED ·Phase: PHASE2

A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures

NCT03116828 ·Status: COMPLETED ·Phase: PHASE4

Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain

NCT06716801 ·Status: RECRUITING

An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures

NCT00744731 ·Status: COMPLETED ·Phase: PHASE3

Prospective Open-label Evaluation of Cenobamate Adjunctive Treatment of Adults With Refractory Focal Epilepsy

NCT04879433 ·Status: UNKNOWN

An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy

NCT00210522 ·Status: COMPLETED ·Phase: PHASE2

Cenobamate in the Intensive Care Unit

NCT06352723 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy

NCT00232596 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures

NCT03288129 ·Status: COMPLETED ·Phase: PHASE4

A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure

NCT00230698 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

NCT05067634 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study in Pediatric Subjects With Epilepsy

NCT01494584 ·Status: TERMINATED ·Phase: PHASE2

A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

NCT00425282 ·Status: COMPLETED ·Phase: PHASE3

Characterization of Epilepsy Patients BEEP 2b

NCT02707965 ·Status: COMPLETED ·Phase: PHASE1

Trobalt™ Products Risk Survey

NCT01721213 ·Status: COMPLETED

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

NCT00866775 ·Status: COMPLETED ·Phase: PHASE3